UNSPSC 51383500: Nonsteroidal anti inflammatory indoles

Nonsteroidal anti inflammatory drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion.

UNSPSC 51383500 Nonsteroidal anti-inflammatory indoles is a Class code, but the recent state and local opportunities tagged under it diverge significantly from the code's pharmaceutical focus — the opportunities actually solicited involve naloxone (an opioid antagonist, not an NSAID), direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products, none of which align with nonsteroidal anti-inflammatory indole compounds. The mismatch suggests the code shows little relevant recent activity matching its nominal scope, or that state and local procurement offices are applying the code inconsistently to broader pharmaceutical procurement categories.

The three most recent opportunities include Seminole County, Florida's IFB for naloxone and drug deactivation systems (posted June 30, 2026, due July 26, 2023), the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs (posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (posted January 20, 2026, due March 26, 2026). Activity spans state health agencies, county health departments, and cooperative purchasing vehicles; Minnesota's MMCAP serves multiple participating states including Oregon. The Seminole County procurement requires quarterly deliveries of 1,900 units of naloxone and 800 safe drug deactivation systems annually with a two-year initial term and one-year renewal option. The MMCAP RFP establishes contracts effective July 1, 2026, through authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) and emphasizes cGMP certification, DSCSA compliance, and pricing flexibility across net and WAC-minus formats. Given the coding mismatch, this code warrants close review before pursuing; the actual pharmaceutical commodity being procured may sit under a different UNSPSC classification.